Physicochemical Characteristics of Nanoparticles Affect Circulation, Biodistribution, Cellular Internalization, and Trafficking
The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
Nanoparticles have many potential applications in tumor therapy. Systemically administered nanoparticles should remain in circulation for a long time to increase their accumulation in targeted tissues before being cleared by the reticuloendothelial system, and be effectively internalized by the targeted cells, which can be influenced significantly by the physicochemical characteristics of nanoparticles, such as particle size, surface properties, and particle shape. This review highlights the impact of the main affects of physicochemical properties on nanoparticle transport behavior in blood, their uptake and clearance by macrophages and their consequent biodistribution, as well as their interaction with targeted cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The most investigated administration route for micelles is the intravenous (i.v.) injection/infusion (mainly exploited for chemotherapy) [18,[47][48][49], but very interesting results in terms of improved drug bioavailability have also been reported following oral [31,50] and topical (ocular, nasal, buccal) [26,36,51,52] administration.”
From Polymeric micelles in drug delivery: An insight of the techniques for their characterization and assessment in biorelevant conditions (2021) · cites this paper as [52]
In the citing paper
“When two charged micelles of Tyr-PEG/PDLLA (neutral) and Tyr-Glu-PEG/PDLLA (anionic) were tested in mice for pharmacokinetics [94], both displayed similar blood clearance kinetics, but anionic micelles showed ~10 times lower biodistribution in liver and spleen compared with neutral micelles, due to synergistic steric and electrostatic repulsion.”
From Recent Advances in Nanomicelles Delivery Systems. (2020) · cites this paper as [94]
Citations
Cites
Understanding biophysicochemical interactions at the nano–bio interface
Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Determining the Size and Shape Dependence of Gold Nanoparticle Uptake into Mammalian Cells
Chithrani, B. D., Ghazani, A. A., & Chan, W. C. W. (2006) · Nano Letters · doi:10.1021/nl052396o · Cited by 4,879
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Renal clearance of quantum dots
Soo Choi, H., Liu, W., Misra, P., Tanaka, E., Zimmer, J. P., Itty Ipe, B., Bawendi, M. G., & Frangioni, J. V. (2007) · Nature Biotechnology · doi:10.1038/nbt1340 · Cited by 4,476
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,180
Research works printed but not linked: 2
- Yuan F., 1995, Cancer Res., 55, 3752
- Matsumura Y., 1986, Cancer Res., 46, 6387
Cited by
Items 901–925 of 925
Silver Staining Technology for Metal Nanoparticles and Their Biological Applications
Mo, L., Luo, C., Gan, S., Tan, Y., & Liu, J. (2026) · Chemistry - A European Journal · doi:10.1002/chem.71260
Siddiqui, F., Khanam, S., Faruqui, T., Mishra, P., Mahmood, S., Mir, S. S., & Khan, S. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05955-0
Luo, L., Lin, S. L., Wang, L., Meng, Y., Zhu, M., & Chen, L. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.05.018 · Cited by 1
Electrophoresis of a slightly deformed spherical charged biocolloid in a gel-like medium
Kundu, N., Dey, B., & Prakash, J. (2026) · Journal of Fluid Mechanics · doi:10.1017/jfm.2026.11833
Nonmetallic nanoparticles: A therapeutic platform for nonmalignant disorders
Mirmasoudi, S. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00021-x
Nonmetallic stimuli-responsive nanocarriers in the treatment of noncancerous disease
Mirmasoudi, S. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.00005-1
Abishek, K. G., Swain, B. K., Jauhari, S., Padil, V. V. T., Gupta, G., Leharwani, M., Kesharwani, P., & Dandela, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33641-6.01002-2
Yi, H., Zheng, Y., Fu, N., Li, Q., Xue, S., Zhan, Z., Guo, L., Li, J., Xh, Y., Shen, J., et al. (2026) · Advanced Healthcare Materials · doi:10.1002/adhm.71484
Engineering strategies and translational progress in targeted nanoparticle drug delivery
Ajay, N., Anilkumar, A. S., & Veerabathiran, R. (2026) · Therapeutic Delivery · doi:10.1080/20415990.2026.2713917
Ismail, M., Wang, N., Li, Y., Li, Y., Yang, Q., Zou, Y., Qin, C., Zheng, M., & Shi, B. (2026) · Biomaterials · doi:10.1016/j.biomaterials.2026.124527 · Cited by 2
Self-citationSpatiotemporal Strategies for Lipid-Based Nanocarriers in Stroke
Xiao, M., Zhang, N., Meng, Q., Zhou, L., Yang, Z., Feng, X., & Bao, C. (2026) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.6c00712
Kamal, F. Z., Lefter, R. M., Burlui, V., Ciobîcă, A. S., -, G. D., Rammali, S., Luca, A., Miler, A. A., Alim, H., Novac, O., et al. (2026) · Cancers · doi:10.3390/cancers18162592
Yu, H., Chen, C., Guo, M., Wang, X., Xu, D., & Sun, W. C. (2026) · Advanced Materials · doi:10.1002/adma.74607 · Cited by 1
Nano-enabled targeted drug delivery systems in green microbial nanotechnology for biomedical
Iyabo, A.-G. G., Adedayo, L. D., Adegbola, P. I., Wali, C., Ogundolie, F. A., Alabi, T. D., Makolo, D., Muftaudeen, T. K., & Onotu, R. O. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36765-6.00009-0
Vannozzi, L., Redondo, J., Trucco, D., Pucci, C., Boccoli, L., Schirru, C., Gherardini, M., Alghilan, W., Parlanti, P., Gemmi, M., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.08.053
Parrot, M., Xu, N., Adnan, M., Cave, J., Ghandehari, H., Nance, E. A., & Yellepeddi, V. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70176 · Cited by 1
Lu, B., Wang, J., Roelofsen, D., Minnema, J., de Winter, D. A. M., Delmaar, C. J. E., Hendriks, A. J., Zillien, C., & Ragas, A. M. J. (2026) · Computational Toxicology · doi:10.1016/j.comtox.2026.100451
Abdullahi, A. S., Iliyasu, S., Zakariya, A., & Lawal, M. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100793
Heparosan based amphiphilic nanomicelles for photodynamic antitumor therapy
Xiao, J., Yin, H., Zha, Z., Liao, Z., & Li, Z. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154683
Nano Delivery Systems for In Vivo CRISPR/Cas-Based Gene Therapy: From Vectors to Clinical Outcomes
Chen, R., Zhou, H., Wu, Q., & Gong, C. (2026) · ACS Nano · doi:10.1021/acsnano.6c12154
Zeng, Y., Lin, C., Yang, J., Fu, M., Ma, J., Mo, L., Yang, H., Li, X., Li, C., Zeng, R., et al. (2026) · ACS Nano · doi:10.1021/acsnano.6c09281
Self-citationKoch, N., & Prasad, R. (2026) · Nanotechnology for Environmental Engineering · doi:10.1007/s41204-026-00620-2
Maboudi, A., Shekari, T., & Zamani, A. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.120018
Chen, C., Fan, X., Song, Y., Wang, S., Li, Z., Wang, P., Hu, Y., Zhu, Y., Ren, F., Zhang, H., et al. (2026) · Materials Today Advances · doi:10.1016/j.mtadv.2026.101034
Metadata
- Authors
- Duan, X., & Li, Y.
- Affiliations
- Shenyang Pharmaceutical University (CN)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Li, Yaping
- Venue
- Small
- Publisher
- Wiley
- Published
- 2012-09-28
- Volume
- 9
- Issue
- 9-10
- Pages
- 1521-1532
- ISSN
- 1613-6810 (ISSN-L)
- 1613-6829
- OpenAlex
- W2039689914
- Cited by
- 926
- References
- 180
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 84 · 2023: 108 · 2022: 98 · 2021: 84 · 2020: 77 · 2019: 79 · 2018: 51 · 2017: 59 · 2016: 54 · 2015: 51 · 2014: 35 · 2013: 18
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Small (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Physical Sciences › Materials Science › Polymers and Plastics › Dendrimers and Hyperbranched Polymers
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- nanoparticles, physicochemical properties, tissue distribution, circulation, cellular internalization, nanoparticle trafficking, particle size, surface properties, particle shape, reticuloendothelial system clearance, macrophage uptake, cancer therapy
- MeSH terms
- Biological Transport, Blood Circulation, Endocytosis, Humans, Surface Properties, Tissue Distribution, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.